20% OFF shipping at ritacall.com on orders over $79 + up to 10% OFF products
ritacall
countryInfoIcon
Ship to:
/ English / USD
Hi, Sign in My Nihao
Hi, Sign in My Nihao
cart
cart
( 0 )
cart
track
All categories
New Arrival
hot img
Air Freeshipping Best Sellers Nihao Choice
header icon
Sourcing
header icon
Shipping Calculation
header icon
Contact us
home > pt141 effects Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction > pt141 effects Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction
pt141 effects Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction
Play video icon
pt141 effects Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction main image 0
pt141 effects Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction main image 1
pt141 effects Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction
pt141 effects Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction
pt141 effects Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction
download picture
description
Report this seller or product
PT 141 Peptide Injection Therapy at Home in Dubai Libido Booster PT 141 Side Effects, Duration, & Benefits Invigor Medical PT 141 Side Effects: What Helps PT 141 Nasal Spray vs Injection: What's the Real Difference?
Shopping security

Shopping security

Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
PT-141 Peptide Injection Therapy at Home in Dubai | Libido Booster
PT-141 Side Effects, Duration, & Benefits | Invigor Medical
PT-141 Side Effects: What Helps
PT-141 Nasal Spray vs Injection: What's the Real Difference?

pt141 effects Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction

Item no : 3355812132
sold recently : Login >>
US$ 24.07
Pay in 4 interest-free payments of $6.02 Learn more
Min. order: 1piece

Shipping Estimate
USAChange
  • USA
  • CAN

Ships within 48 hours · Estimated delivery May 31 - Jun 5

Enjoy 20% off shipping

US$ 24.07

1-11

US$ 21.66

12-35

US$ 16.85

36-59

US$ 14.44

60+

US$ 40
Get now

Sign up to your membership to get coupons up to

15 %
Get now

Opportunity to enjoy order discount up to 15% off

Please add the products

Discover Niche Categories That Outsell pt141 effects

Top-Converting Item to Boost Your Average Order

recommand products

Related Searches

injectable 5 amino 1mq dosage 5-amino-1mq before and after 5-amino-1mq human clinical trial 5 amino 1mq safe 5 amino 1mq daily dose